Overview

Gender

male

A co-founder of GeneriCo, Shu brings over a decade of business and technical expertise in the generic drug industry to his role as VP of Product and Partner Selection. A leader with increasing responsibility at large (Pliva, now part of Teva one of the largest pharmaceutical companies in the world) and specialty pharmaceutical firms Par and KV Pharmaceutical. Shu has a proven track record of growing business through portfolio management and business development and licensing. With an extensive network within the U.S. and Chinese generic drug industry, Shu is able to add significant value to his role as VP Product and Partner Selection. Shu’s relationship with key Chinese businesses within generic drugs adds value to GeneriCo’s global market opportunities. Shu received his Ph.D from Princeton University.